Bausch + Lomb refinances $2.8B term loans; margin cut, maturity extended to 2031

Bausch Health Companies Inc.

$2.802B new Replacement Term Loans to refinance existing term B loans due 2028 and 2031.
Applicable margin reduced by 0.50% (to 3.75%+SOFR) for Third Amendment loans and 0.25% (to 2.75%+ABR) for First Incremental loans.
Maturity extended for First Incremental loans from Sep 29, 2028 to Jan 15, 2031; Third Amendment loans unchanged at 2031.
Transaction expected to close in Q1 2026, subject to conditions; no assurance of completion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.